Cybin (CYBN) Stock Rises Following Positive Trial Results
Fahim Awan
November 18, 2024
After Cybin Inc. (NYSE: CYBN) released encouraging results from its Phase 2 study of CYB003, the company’s shares jumped 11.90% in early trading to $12.98.